Rebecca Whiting
Research Assistant Professor
INP,Ophthalmology,
whitingre@health.missouri.edu
(573) 882-8483
Ex vivo gene therapy for treatment of CLN2 Batten disease using a canine model. We are pursuing combined treatment of the brain and retina to achieve amelioration of all neurologic symptoms in this disease. To learn more about my lab, click here.